Agilent Technologies-What Analyst Projections for Key Metrics Reveal About Agilent (A) Q1 Earnings

Core Insights - Agilent Technologies is expected to report quarterly earnings of $1.27 per share, a decline of 1.6% year-over-year, with revenues forecasted at$ 1.67 billion, reflecting a 0.6% increase compared to the previous year [1] Revenue Estimates by End Markets - Revenue from the Pharmaceutical sector is estimated at $581.36 million, indicating a year-over-year increase of 2.9% [5] - Revenue from Academia and Government is projected to be$ 143.37 million, showing a decline of 4.4% year-over-year [5] - Revenue from Environmental and Forensics is expected to reach $163.16 million, reflecting a decrease of 1.7% year-over-year [6] - Revenue from Chemical and Advanced Materials is forecasted at$ 390.08 million, indicating a slight decline of 0.5% year-over-year [6] - Revenue from the Food sector is anticipated to be $152.57 million, suggesting a year-over-year decrease of 2.8% [6] - Revenue from Diagnostics and Clinical is projected to be$ 237.22 million, reflecting a year-over-year increase of 4% [7] Market Performance - Agilent shares have experienced a return of -10.3% over the past month, contrasting with a +2.2% change in the Zacks S&P 500 composite [7] - The company holds a Zacks Rank of 4 (Sell), indicating expectations of underperformance relative to the overall market in the near future [7]